DailyDoctor Archive Specialties Get app
Back to the 6 October 2026 edition

Clinical update · 01 of 06

Early diagnosis of axial spondyloarthritis was linked to less spinal damage a decade later

Consider shortening diagnostic delay in axial spondyloarthritis; early diagnosis was linked to less spinal damage on a ten-year horizon.

Design
Longitudinal registry analysis with four-parameter logistic modelling of mSASSS
Population
376 patients with axSpA (138 early, 238 established) with at least two spinal radiographs, mean follow-up 11.5 years
Primary outcome
Long-term modified Stoke Ankylosing Spondylitis Spinal Score
Effect
-3.85 units (95% CI -7.28 to -0.42) early vs established; -5.70 (-9.31 to -2.09) after adjustment

This analysis of the Swiss Clinical Quality Management registry compared spinal radiographic progression between early axial spondyloarthritis (symptoms for two years or less at diagnosis) and established disease. It included 376 patients with 1,181 sets of spinal radiographs: 138 early and 238 established, followed for a mean of 11.5 years.

Long-term modified Stoke Ankylosing Spondylitis Spinal Score was lower in the early group (difference -3.85 units, 95% CI -7.28 to -0.42), and the difference grew after adjustment for baseline damage (-5.70, 95% CI -9.31 to -2.09). It became evident only 10 to 15 years after diagnosis. Short-term outcomes had previously been similar between the groups.

This argues for shortening diagnostic delay. The cohort was observational, so patients diagnosed earlier may differ in other ways, such as access to care or disease course.

  • Consider axial spondyloarthritis in young adults with chronic inflammatory back pain, even when radiographs are normal.
  • Refer promptly for rheumatology assessment rather than waiting for radiographic change.
  • Use MRI of the sacroiliac joints where radiographs are negative and suspicion persists.
  • Track structural damage over years, since differences appeared after about a decade.
  • Counsel that earlier diagnosis is associated with less damage, which is not proof of benefit from treatment.

Why it matters

Short-term trials showed no difference by timing, but long-term damage can be shaped by how early the disease is recognised.

Don't overread it

Registry-based and observational; it does not show that earlier treatment, rather than other differences between patients, accounts for the gap.

The statistics, in plain English

A difference of 3.85 to 5.70 mSASSS units is small compared with the 72-point scale but accumulates over decades. The confidence intervals are wide, with the lower limit close to zero for the unadjusted result, so the size of the effect is uncertain.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

spondyloarthritisralupusctdvasculitis

Tomorrow morning, before your first patient

One edition a day for rheumatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app